BRWA
AUPH icon

B. Riley Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

B. Riley Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$97.5K Sell
10,860
-552
-5% -$4.5K ﹤0.01% 1104
2024
Q3 		$82.3K Sell
11,412
-3,334
-23% -$20.7K ﹤0.01% 1221
2024
Q2 		$84.2K Buy
+14,746
New +$77.7K ﹤0.01% 1319

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

B. Riley Wealth Advisors's AUPH Position: Q4 2024 in Review

B. Riley Wealth Advisors reduced its Aurinia Pharmaceuticals (AUPH) stake by 4.8% in Q4 2024, selling an estimated $4.5K and leaving 10,860 shares worth $97.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

B. Riley Wealth Advisors first reported a position in AUPH in Q2 2024 and has held it in 3 quarters since. 200 funds tracked by Wall St. Rank hold AUPH as of Q4 2024.

  • B. Riley Wealth Advisors held 10,860 shares of Aurinia Pharmaceuticals worth $97.5K as of Q4 2024.
  • B. Riley Wealth Advisors sold 552 Aurinia Pharmaceuticals shares in Q4 2024, an estimated $4.5K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of B. Riley Wealth Advisors's portfolio in Q4 2024, its #1104 holding.
  • B. Riley Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 3 quarters since.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2024, filed 25 Feb 2025.